Bronchiolitis Obliterans Syndrome (BOS) Active Not Recruiting Phase 3 Trials for Cyclosporine (DB00091)

Also known as: Obliterative Bronchiolitis / Bronchiolitis Obliterans / Bronchiolitis Obliterans (BO) / Bronchiolitis Obliterans Syndrome / Obliterative bronchiolitis (disorder)

IndicationStatusPhase
DBCOND0071683 (Bronchiolitis Obliterans Syndrome (BOS))Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03656926Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-2)Treatment
NCT03657342Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-1)Treatment